CIAM
STOK icon

Caitong International Asset Management’s Stoke Therapeutics STOK Stock Holding History

Caitong International Asset Management’s Portfolio STOK Stock Details STOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$184K Buy
+5,662
New +$186K 0.03% 409
2025
Q3 		– Sell
-274
Closed -$3.11K – 2484
2025
Q2 		$3.11K Buy
+274
New +$2.6K ﹤0.01% 1222
2025
Q1 		– Sell
-59
Closed -$651 – 2513
2024
Q4 		$651 Buy
+59
New +$725 ﹤0.01% 1414

Other funds holding STOK

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Caitong International Asset Management's STOK Position: Q1 2026 in Review

Caitong International Asset Management opened a new position in Stoke Therapeutics (STOK) in Q1 2026: 5,662 shares worth $184K. The stake represents 0.03% of the portfolio and ranks #409 among its holdings. This is a return to the name: Caitong International Asset Management previously reported a position in STOK as recently as Q2 2025.

Caitong International Asset Management first reported a position in STOK in Q4 2024 and has held it in 3 quarters since. 196 funds tracked by Wall St. Rank hold STOK as of Q1 2026.

  • Caitong International Asset Management held 5,662 shares of Stoke Therapeutics worth $184K as of Q1 2026.
  • Stoke Therapeutics was a new Caitong International Asset Management position in Q1 2026.
  • Stoke Therapeutics made up 0.03% of Caitong International Asset Management's portfolio in Q1 2026, its #409 holding.
  • Caitong International Asset Management first reported a position in Stoke Therapeutics in Q4 2024 and has held it in 3 quarters since.
  • 196 funds tracked by Wall St. Rank held Stoke Therapeutics as of Q1 2026.

Based on Caitong International Asset Management's 13F filing for Q1 2026, filed 11 May 2026.